Cargando…
PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7
Urinary bladder cancer (UBC) is a common malignant tumor with high incidence. Advances in the diagnosis and treatment of this disease demand the identification of novel therapeutic targets. Multiple studies demonstrated that PDE4B level was upregulated in malignancies and high PDE4B expression was c...
Autores principales: | Huang, Zhengnan, Liu, Jiakuan, Yang, Jiale, Yan, Yilin, Yang, Chenkai, He, Xiao, Huang, Ruimin, Tan, Mingyue, Wu, Denglong, Yan, Jun, Shen, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716816/ https://www.ncbi.nlm.nih.gov/pubmed/34977026 http://dx.doi.org/10.3389/fcell.2021.783050 |
Ejemplares similares
-
CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling
por: Huang, Zhengnan, et al.
Publicado: (2021) -
A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2021) -
Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer
por: Hu, Kuan, et al.
Publicado: (2022) -
Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020) -
Establishment of an optimized orthotopic bladder cancer model in mice
por: Cai, Jinming, et al.
Publicado: (2022)